Belumosudil
Back to searchScientific Name: | Belumosudil |
Brand Name: | Rezurock |
Company Owner: | Not Available |
Mechanism Of Action | Chronic graft-versus-host disease (GVHD) is a life-threatening complication of allogeneic hematopoietic stem cell transplantation in which the transplanted donor T-cells recognize the recipient’s tissues as foreign and mount an immune response. |
Description of the Drug: | Belumosudil is an oral inhibitor of rho-associated coiled-coil-containing protein kinases (ROCK) used in the treatment of chronic graft-versus-host disease (GVHD) . |
Protein Data Bank: |
Source: DrugBank Online – DrugBank.com. Retrieved 2023-01-23 from https://go.drugbank.com/drugs/DB16703